Telomerase activity in transthoracic fine-needle biopsy aspirates from non-small cell lung cancer as prognostic factor of patients' survival

Lung Cancer

Volumn 61, Issue 1, 2008, Pages 97-103

  Targowski, Tomasz ^a   Jahnz Rózyk, Karina ^a   Szkoda, Tomasz ^b   Płusa, Tadeusz ^a   From, Sławomir ^a  

^a Military Institute   (Poland)

^b NATIONAL INSTITUTE OF HYGIENE   (Poland)

Author keywords

Fine needle biopsy; Lung cancer; Lung malignant tumours; NSCLC; Prognostic factors; Telomerase

Indexed keywords

ANTINEOPLASTIC AGENT; TELOMERASE;

ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ASSESSMENT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG INFILTRATE; LUNG LESION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; TRANSTHORACIC ASPIRATION;

BIOPSY, FINE-NEEDLE; CARCINOMA, NON-SMALL-CELL LUNG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; POLYMERASE CHAIN REACTION; PROGNOSIS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 45549089511     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.10.017     Document Type: Article

References (30)

1. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
2. Hirashima T., Yoshitaka O., Nitta T., Sasada S., Kobayashi M., Masuda N., et al. Telomerase activity in endoscopically visible lung cancer. Anticancer Res 21 5 (2001) 3685-3689
3. Hiyama K., Hiyama E., Ishioka S., Yamakido M., Inai K., Gazdar F., et al. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 87 (1995) 895-902
4. Marchetti A., Bertacca G., Buttitta F., Chella A., Quattrocolo G., Angeletti C.A., et al. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer. Clin Cancer Res 5 (1999) 2077-2081
5. Telo TAGGG Telomerase PCR ELISA PLUS. Photometric enzyme immunoassay for quantitative determination of telomerase activity, utilizing the telomeric repeat amplification protocol (TRAP). Instruction Manual 1999. Manheim, Germany: Roche Diagnostics; 1999.
6. Travis W.D., Brambilla E., and Müller-Hermelink. Pathology and genetics of tumours of the lung, pleura, thymus and heart. WHO classification of tumours (2004), IARC Press, Lyon p. 1-25
7. Albain K.S., Crowley J.J., LeBlanc M., and Livingston R.B. Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience. J Clin Oncol 9 9 (1991) 1618-1626
8. Espinosa E., Feliu J., Zamora P., Gonzalez Baron M., Sanchez J.J., Ordon ez A., et al. Serum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancer. Lung Cancer 12 1/2 (1995) 67-76
9. Paesmans M., Sculier J.P., Libert P., Bureau G., Dabouis G., Thiriaux J., et al. Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1052 patients. The European Lung Cancer Working Party. J Clin Oncol 13 5 (1995) 1221-1230
10. Pedersen L.M., and Milman N. Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J 9 9 (1996) 1826-1830
11. Roszkowski K. Nowotwory płuc. In: Rowińska-Zakrzewska, and Kuś (Eds). Choroby układu oddechowego (2004), PZWL, Warsaw 563-597
12. Takigawa N., Segawa Y., Okahara M., Maeda Y., Takata I., Kataoka M., et al. Prognostic factors for patients with advanced non-small cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation. Lung Cancer 15 1 (1996) 67-77
13. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
14. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266 (1994) 2011-2015
15. Harley C.B., Futcher A.B., and Greider C.W. Telomeres shorten during aging of human fibroblast. Nature 345 (1990) 458-460
16. Shammas M.A., Koley H., Beer D.G., Li C., Goyal R.K., and Munshi N.C. Growth arrest, apoptosis, and telomere shortening of Barrett's-associated adenocarcinoma cells by a telomerase inhibitor. Gastroenterology 126 5 (2004) 1337-1346
17. Hiyama E., Ishioka S., Shay J.W., Taooka Y., Maeda A., Isobe T., et al. Telomerase activity as a novel marker of lung cancer and immune-associated lung diseases. Int J Mol Med 1 (1998) 545-549
18. Hiyama E., Saeki T., Hiyama K., Takashima S., Shay J.W., Matsuura Y., et al. Telomerase activity as a marker of breast carcinoma in fine-needle aspirated samples. Cancer 90 4 (2000) 235-238
19. Langford L.A., Piatyszek M.A., Xu R., Schold Jr. S.C., and Shay J.W. Telomerase activity in human brain tumors. Lancet 346 (1995) 1267-1268
20. Tahara H., Nakanishi T., Kitamoto M., Nakashio R., Shay J.W., Tahara E., et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinoma. Cancer Res 55 (1995) 2734-2736
21. Xinarianos G., Scott F.M., Liloglou T., Prime W., Turnbull L., Walshaw M., et al. Evaluation of telomerase activity in bronchial lavage as a potential diagnostic marker for malignant lung disease. Lung Cancer 28 (2000) 37-42
22. Fujita Y., Fujikane T., Fujiuchi S., Nishigaki Y., Yamazaki Y., Nagase A., et al. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with non-small cell lung carcinoma. Cancer 98 5 (2003) 1008-1013
23. Strauss G.M., Kwiatkowski D.J., Harpole D.H., Lynch T.J., Skarin A.T., and Sugarbaker D.J. Molecular and pathologic markers in stage I non-small cell carcinoma of the lung. J Clin Oncol 43 (1995) 1269-1279
24. Taga S., Osaki T., Oghami A., Imoto H., and Yasumoto K. Prognostic impact of telomerase activity in non-small cell lung cancers. Ann Surg 230 5 (1999) 715-720
25. Wu T.C., Lin P., Hsu C.P., Huang Y.J., Chen C.Y., Chung W.C., et al. Loss of telomerase activity may be a potential favourable prognostic marker in lung carcinomas. Lung cancer 41 2 (2003) 163-169
26. Chen K.Y., Lee L.N., Yu C.J., Lee Y.C., Kuo S.H., and Yang P.C. Elevation of telomerase activity positively correlates to poor prognosis of patients with non-small cell lung cancer. Cancer Lett 21 (2005) 1-9
27. Zhu C.Q., Cutz J.C., Liu N., Lau D., Shepherd F.A., Squire J.A., et al. Amplification of telomerase gene is a poor prognostic marker in non-small-cell lung cancer. Br J Cancer 94 10 (2006) 1452-1459
28. Ceresoli G.L., Reni M., Chiesa G., Carretta A., Schipani S., Passoni P., et al. Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis. Cancer 95 3 (2002) 605-612
29. Kormas P., Bradshaw J.R., and Jeyasingham K. Preoperative computed tomography of the brain in non small cell bronchogenic carcinoma. Thorax 47 (1992) 106-108
30. Shields T.W. Screening, staging, and diagnostic investigation of non-small cell lung cancer patients. Curr Opin Oncol 3 2 (1991) 297-305